Neuroone Medical Technologies (NMTC) Receivables - Net (2020 - 2026)

Neuroone Medical Technologies (NMTC) has 7 years of Receivables - Net data on file, last reported at $2.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Net rose 661.19% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $2.4 million (up 661.19% YoY), and the FY2025 full-year result was $1.3 million, up 616.05% from the prior year.
• Receivables - Net for Q1 2026 stood at $2.4 million, down from $2.7 million in the prior quarter.
• Across five years, Receivables - Net topped out at $2.7 million in Q4 2025 and bottomed at $33237.0 in Q3 2022.
• The 5-year median for Receivables - Net is $410551.0 (2024), against an average of $854323.1.
• The widest annual swing landed in 2025, when Receivables - Net slumped 42.63%; it then soared 661.19% in 2026.
• A 5-year view of Receivables - Net shows it stood at $95319.0 in 2022, then soared by 470.08% to $543399.0 in 2023, then jumped by 335.94% to $2.4 million in 2024, then climbed by 12.37% to $2.7 million in 2025, then declined by 8.84% to $2.4 million in 2026.
• The last three Receivables - Net figures came in at $2.4 million (Q1 2026), $2.7 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.

Peer Comparison